Cyprenorphine: Difference between revisions
CSV import |
CSV import |
||
| Line 25: | Line 25: | ||
{{stub}} | {{stub}} | ||
== Cyprenorphine gallery == | |||
<gallery> | |||
File:Cyprenorphine Structure.svg|Cyprenorphine Structure | |||
</gallery> | |||
Latest revision as of 05:45, 3 March 2025
Cyprenorphine is an opioid analgesic that was developed in the 1960s. It is a potent antagonist of the mu-opioid receptor, and has been used in scientific research to help understand the function of this receptor.
History[edit]
Cyprenorphine was first synthesized in the 1960s by the pharmaceutical company Hoffmann-La Roche. It was developed as part of a series of related drugs that also includes buprenorphine and diprenorphine, which are still in use today.
Pharmacology[edit]
Cyprenorphine acts as an antagonist at the mu-opioid receptor, which is the primary target of most opioid analgesics. It has a high affinity for this receptor, and can effectively block the effects of other opioids. This has made it a useful tool in scientific research, as it can be used to study the effects of opioids on the body and to develop new treatments for opioid addiction.
Medical uses[edit]
While cyprenorphine is not commonly used in clinical practice, it has been used in scientific research to study the function of the mu-opioid receptor. It has also been used to develop new treatments for opioid addiction, as it can effectively block the effects of other opioids.
Side effects[edit]
Like all opioids, cyprenorphine can cause a range of side effects. These can include nausea, vomiting, constipation, and respiratory depression. It can also cause physical dependence and withdrawal symptoms if used for a long period of time.


